Analysts expect Mercury General Corporation (NYSE:MCY) to report $0.39 EPS on February, 5.They anticipate $0.19 EPS change or 32.76% from last quarter’s $0.58 EPS. MCY’s profit would be $21.58 million giving it 34.42 P/E if the $0.39 EPS is correct. After having $0.60 EPS previously, Mercury General Corporation’s analysts see -35.00% EPS growth. The stock increased 1.40% or $0.74 during the last trading session, reaching $53.69. About 223,442 shares traded or 22.15% up from the average. Mercury General Corporation (NYSE:MCY) has risen 6.61% since January 14, 2017 and is uptrending. It has underperformed by 10.09% the S&P500.
VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet medical needs in the United States and the European Union. The company has market cap of $53.62 million. The firm offers Qsymia for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index of 30 or greater, or 27 or greater in the presence of at least one weight-related comorbidity, such as hypertension, type 2 diabetes mellitus or high cholesterol; and STENDRA, an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction. It has a 1.49 P/E ratio. It is also developing Qsymia, which has completed Phase II studies for the treatment of obstructive sleep apnea and diabetes, as well as for other obesity-related diseases, including nonalcoholic steatohepatitis, nonalcoholic fatty liver disease, hyperlipidemia, and hypertension.
The stock decreased 4.49% or $0.0238 during the last trading session, reaching $0.5061. About 370,529 shares traded. VIVUS, Inc. (VVUS) has declined 7.14% since January 14, 2017 and is downtrending. It has underperformed by 23.84% the S&P500.
Nine Chapters Capital Management Llc holds 0.2% of its portfolio in VIVUS, Inc. for 92,800 shares. Menta Capital Llc owns 156,421 shares or 0.02% of their US portfolio. Moreover, Acadian Asset Management Llc has 0.01% invested in the company for 2.96 million shares. The Pennsylvania-based Ajo Lp has invested 0.01% in the stock. Bridgeway Capital Management Inc, a Texas-based fund reported 637,200 shares.
Analysts await VIVUS, Inc. (NASDAQ:VVUS) to report earnings on March, 14. They expect $-0.13 earnings per share, down 124.07% or $0.67 from last year’s $0.54 per share. After $-0.06 actual earnings per share reported by VIVUS, Inc. for the previous quarter, Wall Street now forecasts 116.67% negative EPS growth.
Among 2 analysts covering Mercury General (NYSE:MCY), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Mercury General had 3 analyst reports since August 26, 2015 according to SRatingsIntel. The firm has “Mkt Perform” rating by Raymond James given on Friday, February 19. The company was maintained on Tuesday, May 3 by Compass Point. The stock has “Sell” rating by Zacks on Wednesday, August 26.
Since August 4, 2017, it had 0 insider buys, and 2 sales for $277,890 activity. 2,355 shares valued at $138,945 were sold by TIRADOR GABRIEL on Friday, August 4.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.